首页> 外国专利> Method for establishing immortalized human tumor endothelial cells and immortalized human tumor endothelial cells

Method for establishing immortalized human tumor endothelial cells and immortalized human tumor endothelial cells

机译:建立永生化人肿瘤内皮细胞和永生化人肿瘤内皮细胞的方法

摘要

An object of the present invention is to obtain an immortalized human-derived tumor vascular endothelial cell useful for cell-based experiments such as compound screening. The present invention provides a cell suspension derived from a tumor tissue containing tumor vascular endothelial cells by performing cell separation using magnetic beads and optional cell separation by flow cytometry to obtain CD31-positive cells. The cell group containing CD31-positive cells is re-isolated by combining subculture of the separated cell group and flow cytometry, and the genes encoding the SV40T gene, hTERT gene and fluorescent protein are expressed. The present invention relates to a method for establishing an immortalized tumor vascular endothelial cell line, comprising transforming with a virus vector as possible, and selecting transformed cells by a combination of subculture and flow cytometry. ADVANTAGE OF THE INVENTION According to this invention, it becomes possible to provide a stable and large quantity of tumor vascular endothelial cells useful for screening of a drug specific to tumor vascular endothelial cells or for developing a drug. [Selection diagram] Fig. 1
机译:本发明的目的是获得永生化的人来源的肿瘤血管内皮细胞,其可用于基于细胞的实验,例如化合物筛选。本发明提供了通过使用磁珠进行细胞分离并通过流式细胞术进行任选的细胞分离以获得CD31阳性细胞而衍生自包含肿瘤血管内皮细胞的肿瘤组织的细胞悬液。通过将分离的细胞群的继代培养和流式细胞术相结合,重新分离含有CD31阳性细胞的细胞群,并表达编码SV40T基因,hTERT基因和荧光蛋白的基因。本发明涉及建立永生化的肿瘤血管内皮细胞系的方法,该方法包括尽可能用病毒载体转化,以及通过传代培养和流式细胞术的组合选择转化的细胞。发明的效果根据本发明,可以提供稳定且大量的肿瘤血管内皮细胞,其对于筛选对肿瘤血管内皮细胞具有特异性的药物或用于开发药物是有用的。 [选择图]图1

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号